Member Info for flyingmachine

Could someone please remind me of the latest profit margin for the NCYT Covid test. I remember Primers profit margin in 2019 improved to 84% but I vaguely remember thinking the actual profit margins of Covid PCR tests (with partner manufacturing) was now around 50-60%?

saint, the insignificant block listing shares hit the market on 4th June, as per today's RNS...."It is expected that the 300,000 Ordinary Shares will be admitted to trading on 4 June 2020." GDR staff taking part in the share options will not have the shares vested to them for probably 3 - 5 years.

x66rjp, we have already calculated that the 300,000 block listing for staff share options to enter the market on 4th June is insignificant - amounts to about 0.66% of share capital of GDR, or translates to equivalent 1.2p of the current share price. Very insignificant and I believe the market has already factored this miniscule impact into the SP today. So no sweat.

FCA definition....."A block listing is a facility that allows an issuer to admit to listing unallotted securities that are
issued over an extended period of time. Block listed securities are admitted to the Official List
when we release the ‘Official List Notice’."

So it is a terminology used to describe a block of shares to be added to the main listing of the company, for example, for staff share options.

I fully anticipate FDA EUA approval for the GDR PCR test to be obtained very soon since most, if not all, validation documentation used to obtain the CE Mark approval can be re-used. It could be tomorrow but more likely next week. Then the USA market is wide open - simpler PCR test, accurate, consistent, reliable and quicker than other PCR tests being used. These particular features of the GDR PCR test make it an attractive proposition for the millions of tests the USA need.

....or good time to bee lieve :-)

Punter, I really don't think it is worth sweating about. It's not unusual, every great company has share options to reward their staff. It's a great signal that after all this time (since 2007) staff now see that now is the opportunity to participate in the reward of their hard work. It's equivalent to only 1.2p to the share price and once folk that sold as soon as they saw the RNS will realize how it's so insignificant and that it is actually a positive message, they'll be bouncing back in.

...and the markets taken 10p off the share price. It makes me wonder if most people who invest take time to read RNSs and work out what they mean and their real impact. Never mind, they'll work it out soon enough

Puner, your right. A slip of a decimal place. Still insignificant, equivalent to about 1.2p of the current share price. Nothing at all.

300,000 shares - so an additional 0.06% share capital added to the GDR company shares on the 4th June. No problem at all, should reward the staff for giving the opportunity to have our rewards. Insignificant and is a further positive signal, since staff want to share in GDR success.

quite agree bigbench, still only £81m market captilisation (Mcap) with an approved top-tier superior Covid PCR test, high volume manufacturing, existing distribution channels worldwide - this product will be sold in the millions over next few weeks and months.

CE Marked and approved Covid test and other products to sell and the Mcap at still only £84m! What an opportunity! Only way this is going is up!

From the information I read from the Gendrive website about their Covid test assays, my understanding is that they will use the same LyoStable technology (from Cytiva) but the POC test chemistry must be different because the POC test does not involve RNA extraction (that may explain why POC test is around 45 min, compared to 100 mins for PCR test).

In the same 25th March RNS they said they ...." will adapt its formulations to run on the Genedrive® instrument platform to provide a rapid point-of-care SARS-COV-2 test ".

So adapting there CE Marked formulation so will not be a 'start from scratch' piece of work from assay perspective. They have probably been adapting their successful formula since start of May when they had readied the lab assay for CE validation.

scart, the gave reasons for longer timelines in 25th March RNS....."The rationale for the two-stage development is that the testing, logistics, validation, and trial work to provide testing on a turnkey instrument system like Genedrive® takes additional time compared to an agnostic assay format"

Equally reliable PCR testing on mobile POC device, excellent.

Spartajones, staying invested here and holding will be rewarded, any 'if' has been scrubbed out tiday so it's only a matter of when. The template of future SP growth has already been laid out. The Gov are following and maintaining control of a constructed plan with timelines to open up the country and economy as quickly and safely as possible. Test and Trace is their initial first step, then immunity passports must follow soon after.

Or it could be the Qwikzyme test being developed quietly in the background by Imperial College London since April. They have EU funding....

https://eithealth.eu/covid-19-rapid-response/qwikzyme/

It mentions the difficulty of gaining high enough sensivity required in rapid antigen tests, especially when in the hands of non-skilled consumers. This challenge is described in this further article here....

https://www.sciencemag.org/news/2020/05/coronavirus-antigen-tests-quick-and-cheap-too-often-wrong?utm_campaign=ScienceNow&utm_source=JHubbard&utm_medium=Facebook

The key is sensitivity, if it isn't high enough (high 90's) it cannot be considered a great Covid test.

rh619, basic fundamental is that GDR has CE approved tests to sell! You are/were in AVCT, did you ask these same questions over there?

rh619, placement shares impact has been worked into the share price over several weeks now, so I see upside from tomorrow onwards. Look at the ridiculously low Mcap of GDR with a CE marked and approved test, manufacturing and sales already underway, FD approval shortly......compare that very low Mcap against other Covid stocks and you should be able to see the potential rapid climb from here!

Kamakiriad, you make a good point. Nothing in AVCT is guaranteed and when I wander over to the Tesco shelf to buy the product, the shelf is empty - but I ask the shop assistant if or when the product arrives, will it clean the oven 100%? They answer 'no', because 'Mr Muscle' can miss up to 20% of the dirt, so best to use professional cleaning if you want 100% cleanliness.....

https://www.sciencemag.org/news/2020/05/coronavirus-antigen-tests-quick-and-cheap-too-often-wrong?utm_campaign=ScienceNow&utm_source=JHubbard&utm_medium=Facebook

There will of course be room for 80% clean ovens in consumer homes, but in most professional kitchens they demand 100% cleanliness.